We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
(+3.8%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$306M |
| 2 |
Cigna
CI
|
+$151M |
| 3 |
Pacira BioSciences
PCRX
|
+$143M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Tenet Healthcare
THC
|
+$99.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$62.4M |
| 3 |
Perrigo
PRGO
|
+$52.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$49.4M |
| 5 |
SKX
Skechers
SKX
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.8% |
| 2 | Financials | 7.09% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Energy | 5.17% |
| 5 | Industrials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPN
701
DELISTED
Calpine Corporation
CPN
| $269K | ﹤0.01% |
18,400
-20,167
| -52% | -$331K |
|
|
CCG
702
DELISTED
CAMPUS CREST COMMUNITIES INC COM STK (MD)
CCG
| $269K | ﹤0.01% |
+50,505
| New | +$277K |
|
703
MSC Industrial Direct
MSM
$6.89B
| $266K | ﹤0.01% |
+4,363
| New | +$297K |
|
704
Union Pacific
UNP
$174B
| $265K | ﹤0.01% |
3,000
-81,291
| -96% | -$7.42M |
|
705
Clorox
CLX
$11.6B
| $264K | ﹤0.01% |
2,285
-552
| -19% | -$62K |
|
706
State Street
STT
$50.6B
| $262K | ﹤0.01% |
3,900
-7,767
| -67% | -$578K |
|
707
eBay
EBAY
$50.6B
| $260K | ﹤0.01% |
10,624
-520,362
| -98% | -$14M |
|
708
Chemours
CC
$2.5B
| $257K | ﹤0.01% |
+39,690
| New | +$415K |
|
|
GES
709
DELISTED
Guess Inc
GES
| $257K | ﹤0.01% |
+12,016
| New | +$260K |
|
710
Nelnet
NNI
$4.88B
| $257K | ﹤0.01% |
7,437
+425
| +6% | +$16.7K |
|
|
SIRO
711
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $257K | ﹤0.01% |
+2,752
| New | +$273K |
|
712
General Dynamics
GD
$104B
| $256K | ﹤0.01% |
1,856
-1,184
| -39% | -$171K |
|
713
American Water Works
AWK
$26.7B
| $255K | ﹤0.01% |
4,621
-2,659
| -37% | -$139K |
|
714
LivePerson
LPSN
$21.8M
| $254K | ﹤0.01% |
+2,238
| New | +$303K |
|
|
UHT
715
Universal Health Realty Income Trust
UHT
$603M
| $254K | ﹤0.01% |
+5,418
| New | +$258K |
|
|
PPLI
716
People Inc
PPLI
$3.09B
| $253K | ﹤0.01% |
+21,660
| New | +$288K |
|
|
USG
717
DELISTED
Usg
USG
| $252K | ﹤0.01% |
9,467
-220,533
| -96% | -$6.47M |
|
718
Churchill Downs
CHDN
$5.88B
| $250K | ﹤0.01% |
11,232
-2,274
| -17% | -$50.4K |
|
719
Bristol-Myers Squibb
BMY
$133B
| $249K | ﹤0.01% |
4,200
+600
| +17% | +$38.1K |
|
720
FirstEnergy
FE
$28B
| $249K | ﹤0.01% |
7,962
-192,548
| -96% | -$6.3M |
|
721
Huntington Ingalls Industries
HII
$12.9B
| $249K | ﹤0.01% |
+2,328
| New | +$265K |
|
|
AMTD
722
DELISTED
TD Ameritrade Holding Corp
AMTD
| $249K | ﹤0.01% |
7,828
-4,967
| -39% | -$174K |
|
|
DFT
723
DELISTED
DuPont Fabros Technology Inc.
DFT
| $249K | ﹤0.01% |
+9,618
| New | +$273K |
|
724
Diageo
DEO
$49B
| $248K | ﹤0.01% |
2,300
-8,629
| -79% | -$958K |
|
725
Casey's General Stores
CASY
$32.2B
| $247K | ﹤0.01% |
+2,399
| New | +$249K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.
- Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
- Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
- Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
- Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
- Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
- Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.
Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.